As Australia continues to strengthen its role as a strategic pharmaceutical distribution hub within the Asia-Pacific region, logistics providers are increasingly being required to demonstrate not only operational capability, but also a deep understanding of Australia’s regulatory expectations for pharmaceutical warehousing and distribution.
Recently, SeerPharma was engaged by a multinational third-party logistics (3PL) provider to design and deliver a specialised training program focused on Australian Good Warehousing Practice (GWP) and Good Distribution Practice (GDP) requirements.
The engagement formed part of the client’s broader strategy to expand its logistics and warehousing operations across the Pacific region. As the organisation explored opportunities to support pharmaceutical supply chains — including the handling of scheduled and high-value medicines — its management team identified the need to better understand the regulatory, operational, and quality expectations associated with pharmaceutical distribution in Australia.
During initial discussions, the client sought guidance on the gaps between its existing warehousing infrastructure, technology platforms, operational processes, and the specific requirements needed to support compliant pharmaceutical distribution operations.
In addition to understanding regulatory obligations, the client also required its personnel to develop sufficient knowledge of Australian GWDP requirements to confidently communicate with potential pharmaceutical sponsors, manufacturers, and business partners.
Drawing on SeerPharma’s extensive experience supporting pharmaceutical manufacturers, sponsors, and 3PL/4PL providers across Australia and the Asia-Pacific region, a tailored two-day intensive training program was developed to address these needs.
The program combined:
Regulatory interpretation
Practical workshops
Real-world inspection insights
Interactive case studies
Gap analysis exercises
This approach ensured that participants could not only understand the regulatory framework, but also apply the concepts in a practical operational context.
Through years of consulting and training engagements with warehousing and distribution organisations, SeerPharma has identified several common areas where traditional logistics operations may not fully align with Australian pharmaceutical compliance expectations.
These commonly include:
Licensing and sponsor accountability models
Handling and governance of scheduled medicines and controlled drugs
Temperature control and excursion management
Stability impact assessment
Documentation and batch traceability requirements
Recall readiness and complaint management
Validation of Warehouse Management Systems (WMS)
Data integrity and audit trail controls
As pharmaceutical sponsors increasingly rely on outsourced logistics partners, regulatory expectations placed upon 3PL providers continue to evolve. Organisations are expected to demonstrate robust Quality Management Systems (QMS), validated processes, and strong governance over storage and distribution activities.
The training program was specifically designed for logistics, warehousing, operations, and quality professionals responsible for establishing or expanding pharmaceutical distribution operations in Australia.
Key topics covered included:
Australian pharmaceutical licensing and regulatory oversight
Roles and responsibilities of sponsors, manufacturers, and distributors
Detailed interpretation of the Australian Code of Good Wholesaling Practice
Quality Management System expectations
Temperature control, monitoring, and excursion management
Documentation, recalls, complaints, and pharmacovigilance
Governance of scheduled medicines and controlled substances
Validation of computerised warehouse systems and data integrity controls
By combining regulatory theory with practical operational examples, the course enabled participants to better understand how Australian expectations compare with international frameworks such as:
EU GDP
US 21 CFR requirements
WHO guidance
A major focus of the program was helping participants develop practical skills that could immediately support operational planning and decision-making.
By the conclusion of the course, participants were able to:
Understand the terminology and expectations of Australian GWDP
Identify legal and operational controls associated with scheduled medicines
Assess gaps between current operations and Australian compliance expectations
Understand sponsor expectations for outsourced warehousing providers
Communicate regulatory requirements more effectively with business partners and pharmaceutical sponsors
Prioritise remediation activities based on compliance risk
Importantly, the training extended beyond theory by incorporating practical workshops and structured self-assessment activities to help attendees evaluate their own operations against Australian GWDP expectations.
The course was structured across six comprehensive modules:
Module 1 – Australian Regulatory Framework for Pharmaceutical Distribution
Participants explored the Australian medicines regulatory system, including the roles of the TGA, state and territory regulators, wholesaler licensing requirements, and accountability models for sponsors, manufacturers, and distributors.
Module 2 – Australian Code of Good Wholesaling Practice - Part 1
This module focused on interpreting the Code of Good Wholesaling Practice, including Quality Management System expectations, governance responsibilities, and documentation requirements.
Module 3 – Facilities, Equipment, and Temperature Control
Topics included warehouse design, segregation requirements, temperature mapping, monitoring systems, calibration, maintenance, and data integrity controls.
Module 4 – Documentation, Traceability, Recalls, and Complaints
Participants examined batch traceability requirements, recall systems, complaints handling, adverse event reporting, pharmacovigilance obligations, and the application of ALCOA+ data integrity principles.
Module 5 – Validation of Warehouse Management Systems and Computerised Distribution Processes
This module addressed regulatory expectations for computerised systems, validation lifecycle requirements, audit trails, data integrity, and common compliance risks associated with Warehouse Management Systems (WMS).
Module 6 – Practical GWDP Gap Analysis Workshop
The final workshop provided participants with a structured approach to performing GWDP gap assessments, identifying operational risks, prioritising remediation actions, and preparing for sponsor or regulatory audits.
As pharmaceutical supply chains become increasingly globalised and regulated, the expectations placed on logistics providers continue to rise. Organisations seeking to support pharmaceutical sponsors must ensure their people, systems, facilities, and processes align with both operational and regulatory expectations.
SeerPharma continues to support pharmaceutical manufacturers, sponsors, wholesalers, and logistics providers through consulting, training, auditing, validation, and quality system support across the Asia-Pacific region.
For organisations looking to establish or expand pharmaceutical warehousing and distribution operations in the Asia-Pacific region, specialised GWDP training can provide a critical foundation for achieving compliance readiness and building confidence with regulators and commercial partners alike.
Contact us to learn more about SeerPharma’s Good Warehousing and Distribution Practice training programs, or how these programs can support your current or planned 3PL/4PL operations in the APAC region.